---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009845"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:53:38.667703+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Fulcrum reports ~$352.3M cash as of Dec 31, 2025; updates presentation for JPM conference

## Summary
- Preliminary unaudited cash, cash equivalents and marketable securities of $352.3M as of December 31, 2025.
- Updated corporate slide presentation (Exhibit 99.1) issued January 12, 2026, containing business and strategic updates.
- Management to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 7:30 a.m. PT.
- Presentation will be webcast live on Fulcrum's investor relations website.

## SEC filing metadata
- accession: 0001193125-26-009845
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312526009845/0001193125-26-009845-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312526009845/fulc-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009845
- JSON: https://secwatch.observer/filing/0001193125-26-009845.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009845.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.